U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564375) titled 'MBA Early Feasibility Study' on April 15.

Brief Summary: The MBA 25-04 study is a prospective, multicenter, non-randomized, single-arm, early feasibility study designed to assess the initial safety of the MBA device through five years following the index endovascular procedure.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Thoracic Aortic Aneurysm Penetrating Aortic Ulcers (PAUs) Thoracic Aortic Dissection Pseudoaneurysm

Intervention: DEVICE: GORE(R) Multibranch Arch Endoprosthesis

Primary Investigational Device

DEVICE: GORE(R) Ascending Stent Graft

Secondary Investigational Device

Recruitment Status: N...